1Loukas, M. et al. (2011) The Lymphatic System: A Historical Perspective, Clinical Anatomy, New York, N.Y., 24, 807-816
2Wiig, H. and Swartz, M. A. (2012) Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer. Physiological Reviews 92, 1005-1060
3Florey, H. (1927) Observations on the contractility of lacteals: Part I. The Journal of Physiology 62, 267-272
4Reddy, N. P. and Staub, N. C. (1981) Intrinsic propulsive activity of thoracic duct perfused in anesthetized dogs. Microvascular Research 21, 183-192
5Trzewik, J. et al. (2001) Evidence for a second valve system in lymphatics: endothelial microvalves. FASEB Journal 15, 1711-1717
6Sabin, FR. (1902) On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. American Journal of Anatomy 1, 367-391
7Srinivasan, R. S. et al. (2007) Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes & Development 21, 2422-2432
8Huntington, G. S. and McClure, C. F. W. (1910) The anatomy and development of the jugular lymph sacs in the domestic cat (Felis domestica). American Journal of Anatomy 10, 177-311
9Wigle, J. T. and Oliver, G. (1999) Prox1 function is required for the development of the murine lymphatic system. Cell 98, 769-778
10van der Putte, S. C. (1975) The development of the lymphatic system in man. Advances in Anatomy, Embryology, and Cell Biology 51, 3-60
11Schulte-Merker, S., Sabine, A. and Petrova, T. V. (2011) Lymphatic vascular morphogenesis in development, physiology, and disease. The Journal of Cell Biology 193, 607-618
12Yang, Y. and Oliver, G. (2014) Development of the mammalian lymphatic vasculature. The Journal of Clinical Investigation 124, 888-97
13Koltowska, K. et al. (2013) Getting out and about: the emergence and morphogenesis of the vertebrate lymphatic vasculature. Development (Cambridge, England) 140, 1857-1870
14Albertine, K. H. and O'Morchoe, C. C. (1980) An Integrated light and electron microscopic study on the existence of intramedullary lymphatics in the dog kidney. Lymphology 13, 100-106
15Cuttino, J. T. et al. (1985) Renal medullary lymphatics: microradiographic, light, and electron microscopic studies in pigs. Lymphology 18, 24-30
16Peirce, EC 2nd. (1944) Renal lymphatics. The Anatomical Record 90, 315-335
17Eliska, O. (1984) Topography of intrarenal lymphatics. Lymphology 17, 135-141
18Kriz, W. (1969) Lymphatic vessels of mammalian kidneys. Verhandlungen der Anatomischen Gesellschaft 63, 25-32
19Lee, H. et al. (2011) Expression of lymphatic endothelium-specific hyaluronan receptor LYVE-1 in the developing mouse kidney. Cell and Tissue Research 343, 429-444
20Tanabe, M. et al. (2012) Development of lymphatic vasculature and morphological characterization in rat kidney. Clinical and Experimental Nephrology 16, 833-842
21Matsui, K. et al. (2003) Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels. Journal of the American Society of Nephrology 14, 1981-1989
22Voss, M. et al. (2009) The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma. BJU International 104, 94-99
23Sakamoto, I. et al. (2009) Lymphatic vessels develop during tubulointerstitial fibrosis. Kidney International 75, 828-838
24Ishikawa, Y. et al. (2006) The human renal lymphatics under normal and pathological conditions. Histopathology 49, 265-273
25Bonsib, S. M. (2006) Renal lymphatics, and lymphatic involvement in sinus vein invasive (pT3b) clear cell renal cell carcinoma: a study of 40 cases. Modern Pathology 19, 746-753
26Holmes, M. J., O'Morchoe, P. J. and O'Morchoe, C. C. (1977) Morphology of the intrarenal lymphatic system. Capsular and hilar communications. The American Journal of Anatomy 149, 333-351
27Bell, R. D. et al. (1968) Renal lymphatics: the internal distribution. Nephron 5, 454-463
28Clark, R. L. and Cuttino, J. T. Jr. (1977) Microradiographic studies of renal lymphatics. Radiology 124, 307-311
29Hirakawa, S. (2011) Regulation of pathological lymphangiogenesis requires factors distinct from those governing physiological lymphangiogenesis. Journal of Dermatological Science 61, 85-93
30Otsuki, Y., Magari, S. and Sugimoto, O. (1986) Lymphatic capillaries in rabbit ovaries during ovulation: an ultrastructural study. Lymphology 19, 55-64
31Martínez-Corral, I. et al. (2012) In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis. Proceedings of the National Academy of Sciences of the United States of America 109, 6223-8
32Zheng, W., Aspelund, A., Alitalo, K. (2014) Lymphangiogenic factors, mechanisms, and applications. The Journal of Clinical Investigation 124, 878-87
33Marino, D. et al. (2013) Activation of the epidermal growth factor receptor promotes lymphangiogenesis in the skin. Journal of Dermatological Science 71, 184-194
34Lee, A. S. et al. (2011) Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis. Cancer Research 71, 4506-4517
35Karkkainen, M. J. et al. (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nature Immunology 5, 74-80
36Benest, AV. et al. (2008) VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis. Cardiovascular Research 78, 315-323
37Rissanen, TT. et al. (2003) VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circulation Research 92, 1098-106
38Alitalo, K. (2011) The lymphatic vasculature in disease. Nature Medicine 17, 1371-1380
39Card, CM., Yu, SS., Swartz, MA. (2014) Emerging roles of lymphatic endothelium in regulating adaptive immunity. The Journal of Clinical Investigation 124, 943-52
40Johnson, L. A. and Jackson, D. G. (2010) Inflammation-induced secretion of CCL21 in lymphatic endothelium is a key regulator of integrin-mediated dendritic cell transmigration. International Immunology 22, 839-849
41Kriehuber, E. et al. (2001) Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. The Journal of Experimental Medicine 194, 797-808
42Randolph, G. J., Angeli, V. and Swartz, M. A. (2005) Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nature Reviews Immunology 5, 617-628
43Haessler, U. et al. (2011) Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19. Proceedings of the National Academy of Sciences of the United States of America 108, 5614-5619
44Wick, N. et al. (2008) Lymphatic precollectors contain a novel, specialized subpopulation of podoplanin low, CCL27-expressing lymphatic endothelial cells. The American Journal of Pathology 173, 1202-1209
45Kerjaschki, D. et al. (2004) Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. Journal of the American Society of Nephrology 15, 603-612
46Johnson, LA. et al. (2006) An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. Journal of Experimental Medicine 203, 2763-2777
47Neusser, M. A. et al. (2010) The chemokine receptor CXCR7 is expressed on lymphatic endothelial cells during renal allograft rejection. Kidney International 77, 801-808
48Mancardi, S. et al. (2003) Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells. Immunology 108, 523-530
49Gardner, L. et al. (2004) The human duffy antigen binds selected inflammatory but not homeostatic chemokines. Biochemical and Biophysical Research Communications 321, 306-312
50Pruenster, M. et al. (2009) The duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nature Immunology 10, 101-108
51Akiyama, T. et al. (2008) Immunohistochemical detection of sphingosine-1-phosphate receptor 1 in vascular and lymphatic endothelial cells. Journal of Molecular Histology 39, 527-533
52Pham, T. H. et al. (2010) Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. The Journal of Experimental Medicine 207, 17-27
53Aoyagi, T. et al. (2012) The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis. Lymphatic Research and Biology 10, 97-106
54Yoon, C. M. et al. (2008) Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways. Blood 112, 1129-1138
55Yin, N. et al. (2011) Targeting lymphangiogenesis after islet transplantation prolongs islet al.lograft survival. Transplantation 92, 25-30
56Kim, J. Y. et al. (2005) Effect of FTY720 on chronic cyclosporine nephropathy in rats. Transplantation 80, 1323-1330
57Long, D. A. and Price, K. L. (2009) Sphingosine kinase-1: a potential mediator of renal fibrosis. Kidney International 76, 815-817
58Kramer, S. et al. (2009) The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy. American Journal of Physiology. Renal Physiology 297, F218-F227
59Loffredo, S. et al. (2014) Immune cells as a source and target of angiogenic and lymphangiogenic factors. Chemical Immunology and Allergy 99, 15-36
60Angeli, V. et al. (2006) B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24, 203-215
61Conrady, C. D. et al. (2012) CD8+ T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis. Journal of Immunology 189, 425-432
62Kataru, RP. et al. (2009) Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113, 5650-5659
63Tan, K. W. et al. (2013) Neutrophils contribute to inflammatory lymphangiogenesis by increasing VEGF-A bioavailability and secreting VEGF-D. Blood 122, 3666-3677
64Ran, S. and Montgomery, K. E. (2012) Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors. Cancers 4, 618-657
65Hall, K. L. et al. (2012) New model of macrophage acquisition of the lymphatic endothelial phenotype. PLoS ONE 7, e31794
66Adair, A. et al. (2007) Peritubular capillary rarefaction and lymphangiogenesis in chronic allograft failure. Transplantation 83, 1542-1550
67Lee, A. S. et al. (2013) Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction. Kidney International 83, 50-62
68Poosti, F. et al. (2012) Targeted inhibition of renal rho kinase reduces macrophage infiltration and lymphangiogenesis in acute renal allograft rejection. European Journal of Pharmacology 694, 111-119
69Suzuki, Y. et al. (2012) Transforming growth factor-beta induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction. Kidney International 81, 865-879
70Yazdani, S. et al. (2012) Proteinuria triggers renal lymphangiogenesis prior to the development of interstitial fibrosis. PLoS ONE 7, e50209
71Heller, F. et al. (2007) The contribution of B cells to renal interstitial inflammation. The American Journal of Pathology 170, 457-468
72Huang, Y. et al. (2014) Identification of novel genes associated with renal tertiary lymphoid organ formation in aging mice. PLoS ONE 9, e91850
73Carragher, D. M., Rangel-Moreno, J. and Randall, T. D. (2008) Ectopic lymphoid tissues and local immunity. Seminars in Immunology 20, 26-42
74Aloisi, F. and Pujol-Borrell, R. (2006) Lymphoid neogenesis in chronic inflammatory diseases. Nature Reviews Immunology 6, 205-217
75Seeger, H., Bonani, M. and Segerer, S. (2012) The role of lymphatics in renal inflammation. Nephrology, Dialysis, Transplantation 27, 2634-2641
76Wick, G. et al. (2013) The immunology of fibrosis. Annual Review of Immunology 31, 107-135
77Zampell, J. C. et al. (2012) CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis. PLoS ONE 7, e49940
78El-Chemaly, S. et al. (2009) Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms. Proceedings of the National Academy of Sciences of the United States of America 106, 3958-3963
79Meinecke, A. K. et al. (2012) Aberrant mural cell recruitment to lymphatic vessels and impaired lymphatic drainage in a murine model of pulmonary fibrosis. Blood 119, 5931-5942
80Sakai, N. et al. (2006) Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proceedings of the National Academy of Sciences of the United States of America 103, 14098-14103
81Oka, M. et al. (2008) Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis. Blood 111, 4571-4579
82Kinashi, H. et al. (2013) TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis. Journal of American Society of Nephrology 24, 1627-1642
83James, JM., Nalbandian, A. and Mukouyama, YS. (2013) TGFβ signaling is required for sprouting lymphangiogenesis during lymphatic network development in the skin. Development 140, 3903-3914
84Podgrabinska, S. et al. (2002) Molecular characterization of lymphatic endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 99, 16069-16074
85Malhotra, D. et al. (2012) Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nature Immunology 13, 499-510
86Zhao, T. et al. (2014) Vascular endothelial growth factor-C: its unrevealed role in fibrogenesis. American Journal of Physiology Heart and Circulatory Physiology 306, H789-H796
87Ling, S. et al. (2009) Crucial role of corneal lymphangiogenesis for allograft rejection in alkali-burned cornea bed. Clinical and Experimental Ophthalmology 37, 874-883
88Tang, X. L. et al. (2010) Blocking neuropilin-2 enhances corneal allograft survival by selectively inhibiting lymphangiogenesis on vascularized beds. Molecular Vision 16, 2354-2361
89Dietrich, T. et al. (2010) Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. Journal of Immunology (Baltimore, MD: 1950) 184, 535-539
90Uehara, H. et al. (2013) Dual suppression of hemangiogenesis and lymphangiogenesis by splice-shifting morpholinos targeting vascular endothelial growth factor receptor 2 (KDR). FASEB Journal 27, 76-85
91Zheng, Y., Lin, H. and Ling, S. (2011) Clinicopathological correlation analysis of (lymph) angiogenesis and corneal graft rejection. Molecular Vision 17, 1694-1700
92Geissler, H. J. et al. (2006) First year changes of myocardial lymphatic endothelial markers in heart transplant recipients. European Journal of Cardio-Thoracic Surgery 29, 767-771
93Dashkevich, A. et al. (2010) Lymph angiogenesis after lung transplantation and relation to acute organ rejection in humans. The Annals of Thoracic Surgery 90, 406-411
94Stuht, S. et al. (2007) Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol biopsies. American Journal of Transplantation 7, 377-384
95Nykanen, A. I. et al. (2010) Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts. Circulation 121, 1413-1422
96Vass, D. G. et al. (2012) Inflammatory lymphangiogenesis in a rat transplant model of interstitial fibrosis and tubular atrophy. Transplant International 25, 792-800
97Rienstra, H. et al. (2010) Differential expression of proteoglycans in tissue remodeling and lymphangiogenesis after experimental renal transplantation in rats. PLoS ONE 5, e9095
98Palin, N. K., Savikko, J. and Koskinen, P. K. (2013) Sirolimus inhibits lymphangiogenesis in rat renal allografts, a novel mechanism to prevent chronic kidney allograft injury. Transplant International 26, 195-205
99Huber, S. et al. (2007) Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis. Kidney International 71, 771-777
100Ersoy, A. and Koca, N. (2012) Everolimus-induced lymphedema in a renal transplant recipient: a case report. Experimental and Clinical Transplantation 10, 296-298
101Mendez, U. et al. (2012) Functional recovery of fluid drainage precedes lymphangiogenesis in acute murine foreleg lymphedema. American Journal of Physiology. Heart and Circulatory Physiology 302, H2250-H2256
102Rodriguez-Iturbe, B., Herrera-Acosta, J. and Johnson, R. J. (2002) Interstitial inflammation, sodium retention, and the pathogenesis of nephrotic edema: a unifying hypothesis. Kidney International 62, 1379-1384
103Zhang, T. et al. (2008) Disturbance of lymph circulation develops renal fibrosis in rats with or without contralateral nephrectomy. Nephrology (Carlton, VIC) 13, 128-138
104Zhang, T. et al. (2009) Functional, histological and biochemical consequences of renal lymph disorder in mononephrectomized rats. Journal of Nephrology 22, 109-116
105Choi, I. et al. (2012) 9-cis retinoic acid promotes lymphangiogenesis and enhances lymphatic vessel regeneration: therapeutic implications of 9-cis retinoic acid for secondary lymphedema. Circulation 125, 872-882
106Szuba, A. et al. (2002) Therapeutic lymphangiogenesis with human tecombinant VEGF-C. FASEB Journal 16, 1985-1987
107Cheung, L. et al. (2006) An rxperimental model for the dtudy of lymphedema and its tesponse to yherapeutic lymphangiogenesis. Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 20, 363-370
108Planas-Paz, L. et al. (2012) Mechanoinduction of lymph vessel expansion. EMBO Journal 31, 788-804
109Machnik, A. et al. (2009) Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nature Medicine 15, 545-552
110Machnik, A. et al. (2010) Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats. Hypertension 55, 755-761
111Wiig, H. et al. (2013) Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. Journal of Clinical Investigation 123, 2803-2815
112Slagman, M. C. et al. (2012) Vascular endothelial growth factor C levels are modulated by dietary salt intake in proteinuric chronic kidney disease patients and in healthy subjects. Nephrology, Dialysis, Transplantation 27, 978-982
113Lely, A. T. et al. (2013) Circulating lymphangiogenic factors in preeclampsia. Hypertension in Pregnancy 32, 42-49
114Toering, T. J., Navis, G. and Lely, A. T. (2013) The role of the VEGF-C signaling pathway in preeclampsia? Journal of Reproductive Immunology 100, 128
115Mono, JA. et al. (2014) Role of chemokines in proteinuric kidney disorders.Expert Reviews in Molecular Medicine, 16, e3
116Liersch, R. et al. (2012) Analysis of a novel highly metastatic melanoma cell line identifies osteopontin as a new lymphangiogenic factor. International Journal of Oncology 41, 1455-1463
117Moriguchi, P. et al. (2005) Lymphatic system changes in diabetes mellitus: role of insulin and hyperglycemia. Diabetes/Metabolism Research and Reviews 21, 150-157
118Haemmerle, M. et al. (2013) Enhanced lymph vessel density, remodeling, and inflammation are reflected by gene expression signatures in dermal lymphatic endothelial cells in Type 2 diabetes. Diabetes 62, 2509-2529
119Kivela, R. et al. (2007) Effects of acute exercise, exercise training, and diabetes on the expression of lymphangiogenic growth factors and lymphatic vessels in skeletal muscle. American Journal of Physiology. Heart and Circulatory Physiology 293, H2573-H2579
120Yin, N. et al. (2011) Lymphangiogenesis is required for pancreatic islet inflammation and diabetes. PLoS ONE 6, e28023
121Uchiyama, T. et al. (2013) Altered dynamics in the renal lymphatic circulation of Type 1 and Type 2 diabetic mice. Acta Histochemica et Cytochemica 46, 97-104
122Karaman, S., and Detmar, M. (2014) Mechanisms of lymphatic metastasis. The Journal of Clinical Investigation 124, 922-928
123Lin, J. et al. (2005) Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor. Cancer Research 65, 6901-6909
124Bierer, S. et al. (2008) Lymphangiogenesis in kidney cancer: expression of VEGF-C, VEGF-D and VEGFR-3 in clear cell and papillary renal cell carcinoma. Oncology Reports 20, 721-725
125Horiguchi, A. et al. (2008) Intratumoral lymphatics and lymphatic invasion are associated with tumor aggressiveness and poor prognosis in renal cell carcinoma. Urology 71, 928-932
126Ozardili, I. et al. (2012) Correlation between lymphangiogenesis and clinicopathological parameters in renal cell carcinoma. Singapore Medical Journal 53, 332-335
127Debinski, P. et al. (2013) The clinical significance of lymphangiogenesis in renal cell carcinoma. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 19, 606-611
128Baldewijns, M. M. et al. (2009) A low frequency of lymph node metastasis in clear-cell renal cell carcinoma is related to low lymphangiogenic Activity. BJU International 103, 1626-1631
129Iwata, T. et al. (2008) Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: association with vascular endothelial growth factors A to D immunohistochemistry. Urology 71, 749-754
130Ishikawa, Y. et al. (2007) Significance of lymphatic invasion and proliferation on regional lymph node metastasis in renal cell carcinoma. American Journal of Clinical Pathology 128, 198-207
131Eisenberg, M. S. et al. (2013) Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinoma. The Journal of Urology 190, 37-43
132Kroeger, N. et al. (2012) Clinical, molecular, and genetic correlates of lymphatic spread in clear cell renal cell carcinoma. European Urology 61, 888-895
